Viewing nowCombinationEmpavex Tablet 5/850 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Seoul Pharmaceutical Co., Ltd.

MFDS item code 202501668 · Approved 2025.07.04 · Insurance code 652904730
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used in combination with empagliflozin and metformin to effectively enhance blood sugar control in adults with type 2 diabetes alongside dietary and exercise therapy. It is particularly suitable for adult patients whose blood sugar is not adequately controlled, and caution is needed for patients with confirmed cardiovascular diseases regarding the occurrence of cardiovascular events. Therefore, this medication helps improve blood sugar management and assists in the treatment of type 2 diabetes.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of the individual components: empagliflozin 25 mg and metformin 2000 mg. For patients who do not achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current dose of metformin. If the patient tolerates empagliflozin 10 mg (total daily dose) well but requires additional glycemic control, the dose may be increased to empagliflozin 25 mg (total daily dose). Patients switching to this medicine from concomitant therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive the same doses of empagliflozin and metformin as they were previously taking. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see sections 4. Adverse Reactions and 6. Interactions under Precautions for Use). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take twice the dose at one time; in this case, skip the missed dose. No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual single-ingredient products empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be monitored carefully every 3-6 months (see section 3. Patients Requiring Caution in Use, item 1) under Precautions for Use). If renal function declines to CrCl <45 ml/min or eGFR <45 ml/min/1.73m2, this medicine should be discontinued immediately (see section 2. Patients in Whom This Medicine Must Not Be Used, item 2) under Precautions for Use). In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.
This medication helps to control blood sugar levels. However, there is a risk of serious side effects such as lactic acidosis when taking this medication, so caution is necessary. Particularly, patients with impaired kidney function or those with severe infections or dehydration should be cautious as taking this medication may pose risks. Furthermore, patients with type 1 diabetes or those with acute metabolic acidosis should not use this medication. If undergoing surgery or procedures using iodine contrast agents, this medication should be temporarily discontinued. This medication may increase the risk of hypoglycemia when used in conjunction with other diabetes medications such as insulin or sulfonylureas. While taking this medication, regular monitoring of kidney function is required, and extra caution is necessary in cases of dehydration symptoms or gastrointestinal disturbances. This medication may increase the risk of urinary tract infections or genital infections, so if any infection symptoms arise, consultation with a physician is necessary. It is advisable for pregnant or breastfeeding women not to take this medication. Elderly patients or those with reduced kidney function require dose adjustment and regular monitoring. In case of overdose, seek medical attention immediately.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture from entering. It is important to maintain a storage temperature between 1 and 30 degrees Celsius.
White, oval, biconvex film-coated tablets with a yellow tint
60 tablets/bottle, 60 tablets/box [10 tablets/PTP x 6]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Seoul Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.